What is the recommended follow-up for a patient with cytopathologic changes suggestive of herpes (Human Papillomavirus) on Pap (Papanicolaou) cytology?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Cytopathologic Changes Suggestive of Herpes on Pap Cytology

Cytopathologic changes suggestive of herpes simplex virus (HSV) on Pap smear do not require colposcopy or specific treatment in asymptomatic patients; repeat Pap testing in 6-12 months is the appropriate follow-up to ensure resolution and exclude underlying cervical dysplasia.

Important Clarification

The question appears to conflate herpes simplex virus (HSV) with human papillomavirus (HPV), which are distinct viral infections with different management approaches. The provided evidence primarily addresses HPV and cervical intraepithelial neoplasia (CIN), not HSV cytopathologic changes. This response addresses HSV cytologic findings specifically.

Management Algorithm for HSV Cytologic Changes

Initial Assessment

  • No immediate intervention required: HSV cytologic changes alone (multinucleation, ground-glass nuclei, molding) represent a benign viral infection and do not indicate premalignant disease 1

  • Evaluate for clinical symptoms: If the patient has vulvar or cervical ulcerations, dysuria, or other symptoms consistent with active HSV infection, consider antiviral therapy (acyclovir or valacyclovir) 2, 1

  • Rule out concurrent dysplasia: HSV changes can coexist with HPV-related lesions, so ensure the cytology report does not also indicate squamous intraepithelial lesions 2, 3

Follow-Up Strategy

  • Repeat Pap smear in 6-12 months: This allows confirmation that HSV changes have resolved and ensures no underlying dysplasia was masked by the inflammatory changes 4

  • Return to routine screening: Once a repeat Pap smear shows resolution of HSV changes and no dysplasia, resume age-appropriate cervical cancer screening intervals 4

When Colposcopy IS Indicated

  • Concurrent dysplasia on cytology: If the Pap smear shows both HSV changes AND atypical squamous cells of undetermined significance (ASCUS) with suspected neoplasia, low-grade squamous intraepithelial lesion (LSIL), or high-grade squamous intraepithelial lesion (HSIL), proceed to colposcopy 4

  • Persistent abnormalities: If repeat Pap smear at 6-12 months continues to show HSV changes or develops new cytologic abnormalities ≥ASCUS, colposcopy is warranted 4

  • Atypical clinical presentation: If physical examination reveals a cervical mass or lesion concerning for malignancy, colposcopy with biopsy is necessary regardless of cytology 1

Common Pitfalls to Avoid

  • Do not perform colposcopy for isolated HSV changes: Unlike HPV-related dysplasia, HSV cytologic findings alone do not require colposcopic evaluation 5

  • Do not treat asymptomatic HSV cytologic findings: Antiviral therapy is reserved for symptomatic infections; cytologic evidence alone does not warrant treatment 2

  • Do not confuse HSV with HPV: HSV causes viral cytopathic changes but does not cause cervical dysplasia or cancer, whereas HPV is the causative agent of CIN and cervical cancer 1, 3

  • Ensure adequate follow-up: Patient adherence to repeat testing is critical, as approximately 27% of patients may default from follow-up 6

Special Populations

  • Immunocompromised patients: HIV-infected women with HSV cytologic changes should follow the same algorithm but require more frequent Pap smears (twice in the first year, then annually) due to increased risk of HPV-related dysplasia 4

  • Pregnant women: HSV cytologic changes in pregnancy do not alter management; repeat Pap testing postpartum is appropriate 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.